Biogen Inc vs Suncor Energy Inc. — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Suncor Energy Inc. trades at $63.4 (market cap $74.07B). The key difference: Suncor Energy Inc. is far larger — about 2.5× Biogen Inc's market cap, and Suncor Energy Inc. pays a 2.7% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | SU | |
|---|---|---|
Market Cap | $30.13B | $74.07B |
Sector | Health | Energy |
52-Week High | $216.63 | $69.73 |
52-Week Low | $128.93 | $38.17 |
Enterprise Value | $37.20B | $80.75B |
Dividend Yield | — | 2.7% |
Trailing returns across standard periods
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →